文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Retraction: Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysis.撤稿声明：PD-1/PD-L1抑制剂联合化疗药物对非小细胞肺癌的预后影响：系统评价与荟萃分析

Front Oncol. 2024 Feb 19;14:1383366. doi: 10.3389/fonc.2024.1383366. eCollection 2024.

2

Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysis.PD-1/PD-L1抑制剂联合化疗药物对非小细胞肺癌的预后影响：系统评价与荟萃分析

Front Oncol. 2023 Apr 19;13:1137913. doi: 10.3389/fonc.2023.1137913. eCollection 2023.

3

Retraction: Meta analysis of clinical prognosis of radiofrequency ablation versus partial nephrectomy in the treatment of early renal cell carcinoma.撤稿声明：射频消融术与部分肾切除术治疗早期肾细胞癌临床预后的Meta分析

Front Oncol. 2024 Feb 20;14:1383353. doi: 10.3389/fonc.2024.1383353. eCollection 2024.

4

Retraction: Effects of Aidi injection on life quality and incidence of adverse reactions in patients with non-small cell lung cancer compared with traditional chemotherapy: a systematic review and meta-analysis.撤稿声明：与传统化疗相比，艾迪注射液对非小细胞肺癌患者生活质量及不良反应发生率的影响：一项系统评价与Meta分析。

Front Oncol. 2024 Feb 19;14:1383346. doi: 10.3389/fonc.2024.1383346. eCollection 2024.

5

Corrigendum: Incidence and Prognostic Significance of PD-L1 Expression in High-Grade Salivary Gland Carcinoma.勘误：高级别涎腺癌中PD-L1表达的发生率及预后意义

Front Oncol. 2021 Dec 30;11:836903. doi: 10.3389/fonc.2021.836903. eCollection 2021.

6

Safety and Efficacy of PD-1/PD-L1 inhibitors combined with radiotherapy in patients with non-small-cell lung cancer: a systematic review and meta-analysis.PD-1/PD-L1 抑制剂联合放疗治疗非小细胞肺癌患者的安全性和疗效：系统评价和荟萃分析。

Cancer Med. 2021 Feb;10(4):1222-1239. doi: 10.1002/cam4.3718. Epub 2021 Jan 19.

7

Benefits of combination therapy with immune checkpoint inhibitors and predictive role of tumour mutation burden in hepatocellular carcinoma: A systematic review and meta-analysis.免疫检查点抑制剂联合治疗的益处及肿瘤突变负担在肝细胞癌中的预测作用：系统评价和荟萃分析。

Int Immunopharmacol. 2022 Nov;112:109244. doi: 10.1016/j.intimp.2022.109244. Epub 2022 Sep 18.

8

Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway.撤稿声明：丹参酮IIA和顺铂联合通过下调NF-κB/COX-2/VEGF通路抑制食管鳞状细胞癌

Front Oncol. 2021 Jun 29;11:721658. doi: 10.3389/fonc.2021.721658. eCollection 2021.

9

HIF1 α/PD-L1 Axis Mediates Hypoxia-Induced Cell Apoptosis and Tumor Progression in Follicular Thyroid Carcinoma [Retraction].

Onco Targets Ther. 2022 Nov 21;15:1403-1404. doi: 10.2147/OTT.S397860. eCollection 2022.

10

Retracted: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.撤回：PD-1/PD-L1抑制剂与化疗治疗晚期非小细胞肺癌的临床疗效与安全性分析：一项系统评价与Meta分析。

Biomed Res Int. 2022 Dec 25;2022:9808495. doi: 10.1155/2022/9808495. eCollection 2022.

撤稿声明：PD-1/PD-L1抑制剂联合化疗药物对非小细胞肺癌的预后影响：系统评价与荟萃分析

Retraction: Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysis.

出版信息

Front Oncol. 2024 Feb 19;14:1383366. doi: 10.3389/fonc.2024.1383366. eCollection 2024.

DOI:10.3389/fonc.2024.1383366

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10910229/

Abstract

[This retracts the article DOI: 10.3389/fonc.2023.1137913.].

摘要

[本文撤回文章DOI: 10.3389/fonc.2023.1137913。]